Cargando…
The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndrome
In patients with acute coronary syndromes (ACS), early therapy with high-dose statins may reduce short-term adverse clinical outcomes. The mechanisms responsible are not known but could involve anti-inflammatory or anti-thrombotic effects. Compelling evidence from experimental models and clinical st...
Autores principales: | Sexton, Travis R., Wallace, Eric L., Macaulay, Tracy E., Charnigo, Richard J., Evangelista, Virgilio, Campbell, Charles L., Bailey, Alison L., Smyth, Susan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4320305/ https://www.ncbi.nlm.nih.gov/pubmed/25307674 http://dx.doi.org/10.1007/s11239-014-1142-x |
Ejemplares similares
-
Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At
the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte
Interactions
por: Sexton, Travis, et al.
Publicado: (2016) -
Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia
por: Sexton, Travis R., et al.
Publicado: (2018) -
Platelets, Thromboinflammation and Neurovascular Disease
por: Sun, Ying, et al.
Publicado: (2022) -
Thromboinflammation and the hypercoagulability of COVID‐19
por: Connors, Jean M., et al.
Publicado: (2020) -
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies
por: Marsh, Phillip L., et al.
Publicado: (2023)